Zdrowie i gospodarka · 11/04/2024
FDA Clears Path for Baclofen Orally Disintegrating Tablets
The FDA has determined that KEMSTRO (baclofen) orally disintegrating tablets, 10 mg and 20 mg, were not withdrawn from sale due to safety or effectiveness concerns, paving the way for potential approval of generic versions.